229 related articles for article (PubMed ID: 18922901)
1. Semaphorin 3B inhibits the phosphatidylinositol 3-kinase/Akt pathway through neuropilin-1 in lung and breast cancer cells.
Castro-Rivera E; Ran S; Brekken RA; Minna JD
Cancer Res; 2008 Oct; 68(20):8295-303. PubMed ID: 18922901
[TBL] [Abstract][Full Text] [Related]
2. Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effect.
Castro-Rivera E; Ran S; Thorpe P; Minna JD
Proc Natl Acad Sci U S A; 2004 Aug; 101(31):11432-7. PubMed ID: 15273288
[TBL] [Abstract][Full Text] [Related]
3. Role of the phosphatidylinositol 3'-kinase/PTEN/Akt kinase pathway in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in non-small cell lung cancer cells.
Kandasamy K; Srivastava RK
Cancer Res; 2002 Sep; 62(17):4929-37. PubMed ID: 12208743
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B.
Tomizawa Y; Sekido Y; Kondo M; Gao B; Yokota J; Roche J; Drabkin H; Lerman MI; Gazdar AF; Minna JD
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13954-9. PubMed ID: 11717452
[TBL] [Abstract][Full Text] [Related]
5. Semaphorin-3B is an angiogenesis inhibitor that is inactivated by furin-like pro-protein convertases.
Varshavsky A; Kessler O; Abramovitch S; Kigel B; Zaffryar S; Akiri G; Neufeld G
Cancer Res; 2008 Sep; 68(17):6922-31. PubMed ID: 18757406
[TBL] [Abstract][Full Text] [Related]
6. GATA3 targets semaphorin 3B in mammary epithelial cells to suppress breast cancer progression and metastasis.
Shahi P; Wang CY; Chou J; Hagerling C; Gonzalez Velozo H; Ruderisch A; Yu Y; Lai MD; Werb Z
Oncogene; 2017 Oct; 36(40):5567-5575. PubMed ID: 28581515
[TBL] [Abstract][Full Text] [Related]
7. Allelic loss on chromosome 3p21.3 and promoter hypermethylation of semaphorin 3B in non-small cell lung cancer.
Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Williams NN; Kaiser LR; Croce CM
Cancer Res; 2003 Jun; 63(12):3352-5. PubMed ID: 12810670
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor binding protein-3 inhibits the growth of non-small cell lung cancer.
Lee HY; Chun KH; Liu B; Wiehle SA; Cristiano RJ; Hong WK; Cohen P; Kurie JM
Cancer Res; 2002 Jun; 62(12):3530-7. PubMed ID: 12068000
[TBL] [Abstract][Full Text] [Related]
9. Hormonal regulation and distinct functions of semaphorin-3B and semaphorin-3F in ovarian cancer.
Joseph D; Ho SM; Syed V
Mol Cancer Ther; 2010 Feb; 9(2):499-509. PubMed ID: 20124444
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of akt/protein kinase B signaling by naltrindole in small cell lung cancer cells.
Chen YL; Law PY; Loh HH
Cancer Res; 2004 Dec; 64(23):8723-30. PubMed ID: 15574783
[TBL] [Abstract][Full Text] [Related]
11. Α-eleostearic acid inhibits growth and induces apoptosis in breast cancer cells via HER2/HER3 signaling.
Zhuo RJ; Wang F; Zhang XH; Zhang JJ; Xu J; Dong W; Zou ZQ
Mol Med Rep; 2014 Mar; 9(3):993-8. PubMed ID: 24425042
[TBL] [Abstract][Full Text] [Related]
12. Progesterone and 1,25-dihydroxyvitamin D₃ inhibit endometrial cancer cell growth by upregulating semaphorin 3B and semaphorin 3F.
Nguyen H; Ivanova VS; Kavandi L; Rodriguez GC; Maxwell GL; Syed V
Mol Cancer Res; 2011 Nov; 9(11):1479-92. PubMed ID: 21933904
[TBL] [Abstract][Full Text] [Related]
13. A novel herbal formula induces cell cycle arrest and apoptosis in association with suppressing the PI3K/AKT pathway in human lung cancer A549 cells.
Xiong F; Jiang M; Huang Z; Chen M; Chen K; Zhou J; Yin L; Tang Y; Wang M; Ye L; Zhan Z; Duan J; Fu H; Zhang X
Integr Cancer Ther; 2014 Mar; 13(2):152-60. PubMed ID: 24105357
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte growth factor-mediated cell invasion in pancreatic cancer cells is dependent on neuropilin-1.
Matsushita A; Götze T; Korc M
Cancer Res; 2007 Nov; 67(21):10309-16. PubMed ID: 17974973
[TBL] [Abstract][Full Text] [Related]
15. Response to epidermal growth factor receptor inhibitors in non-small cell lung cancer cells: limited antiproliferative effects and absence of apoptosis associated with persistent activity of extracellular signal-regulated kinase or Akt kinase pathways.
Janmaat ML; Kruyt FA; Rodriguez JA; Giaccone G
Clin Cancer Res; 2003 Jun; 9(6):2316-26. PubMed ID: 12796401
[TBL] [Abstract][Full Text] [Related]
16. Decreased apoptosis in polyamine depleted IEC-6 cells depends on Akt-mediated NF-kappaB activation but not GSK3beta activity.
Bhattacharya S; Ray RM; Johnson LR
Apoptosis; 2005 Aug; 10(4):759-76. PubMed ID: 16133867
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of phosphatidylinositol 3'-kinase/AKT signaling promotes apoptosis of primary effusion lymphoma cells.
Uddin S; Hussain AR; Al-Hussein KA; Manogaran PS; Wickrema A; Gutierrez MI; Bhatia KG
Clin Cancer Res; 2005 Apr; 11(8):3102-8. PubMed ID: 15837766
[TBL] [Abstract][Full Text] [Related]
18. A synthetic naringenin derivative, 5-hydroxy-7,4'-diacetyloxyflavanone-N-phenyl hydrazone (N101-43), induces apoptosis through up-regulation of Fas/FasL expression and inhibition of PI3K/Akt signaling pathways in non-small-cell lung cancer cells.
Bak Y; Kim H; Kang JW; Lee DH; Kim MS; Park YS; Kim JH; Jung KY; Lim Y; Hong J; Yoon DY
J Agric Food Chem; 2011 Sep; 59(18):10286-97. PubMed ID: 21877710
[TBL] [Abstract][Full Text] [Related]
19. Marine lipopeptide Iturin A inhibits Akt mediated GSK3β and FoxO3a signaling and triggers apoptosis in breast cancer.
Dey G; Bharti R; Dhanarajan G; Das S; Dey KK; Kumar BN; Sen R; Mandal M
Sci Rep; 2015 May; 5():10316. PubMed ID: 25974307
[TBL] [Abstract][Full Text] [Related]
20. DC120, a novel and potent inhibitor of AKT kinase, induces tumor cell apoptosis and suppresses tumor growth.
Deng R; Yang F; Chang SH; Tang J; Qin J; Feng GK; Ding K; Zhu XF
Mol Pharmacol; 2012 Aug; 82(2):189-98. PubMed ID: 22553359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
